Biotech

All Articles

Basilea credit ratings $268M BARDA backing for antifungals, prescription antibiotics

.Basilea Pharmaceutica's work cultivating new antifungals has gotten a notable improvement from the ...

Capricor markets Europe civil liberties to late-stage DMD treatment for $35M

.Having currently scooped up the U.S. legal rights to Capricor Therapeutics' late-stage Duchenne mus...

FDA scraps adcomm for Applied's uncommon condition medicine

.After pushing the selection meeting for Applied Rehabs' metabolic disorder medication govorestat, t...

Novo inks $600M NanoVation deal to study genetic medications ex-liver

.Novo Nordisk is actually continuing its press into hereditary medicines, consenting to pay NanoVati...

Innovent web links cytokine to intestines cancer reactions

.Innovent Biologics has actually helped make the situation that its gate inhibitor-cytokine combinat...

Merck, Daiichi ADC reaches objective in phase 3 bronchi cancer research study

.A stage 3 trial of Daiichi Sankyo and also Merck &amp Co.'s HER3-directed antibody-drug conjugate (...

Rakovina grows artificial intelligence center along with collab to decide on cancer targets

.Five months after Rakovina Therapeutics turned towards expert system, the cancer-focused biotech ha...

Ascendis' dwarfism medication smash hits in period 3, endangers BioMarin

.Ascendis Pharma has emerged as a possible threat to BioMarin's Voxzogo, stating period 3 developmen...

Despite ph. 3 skip, Alkeus observes pathway in advance for eye condition possession

.Though Alkeus Pharmaceuticals' dental eye health condition resource stopped working to considerably...

Kairos goes public with $6M IPO to money trials of cancer cells medication

.Along with a trio of biotechs reaching the Nasdaq on Friday, it was easy to miss out on a smaller-s...